These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24064800)

  • 81. Anticancer effect of caudatin in diethylnitrosamine‑induced hepatocarcinogenesis in rats.
    Song J; Ding W; Liu B; Liu D; Xia Z; Zhang L; Cui L; Luo Y; Jia X; Feng L
    Mol Med Rep; 2020 Aug; 22(2):697-706. PubMed ID: 32626931
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Caudatin Isolated from
    Zhen X; Choi HS; Kim JH; Kim SL; Liu R; Ko YC; Yun BS; Lee DS
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32570844
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cleistanthin A inhibits the invasion of MDA-MB-231 human breast cancer cells: involvement of the β-catenin pathway.
    Liu S; Wang L; Ding W; Wang D; Wang X; Luo Q; Lu Y; Zhu L
    Pharmacol Rep; 2020 Feb; 72(1):188-198. PubMed ID: 32016834
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antiangiogenic properties of caudatin in vitro and in vivo by suppression of VEGF‑VEGFR2‑AKT/FAK signal axis.
    Wang X; Fu X; Zhao S; Fu X; Zhang H; Shao L; Li G; Fan C
    Mol Med Rep; 2017 Dec; 16(6):8937-8943. PubMed ID: 28990104
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
    Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
    Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
    [TBL] [Abstract][Full Text] [Related]  

  • 86. CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma.
    Jiang L; Yang YD; Fu L; Xu W; Liu D; Liang Q; Zhang X; Xu L; Guan XY; Wu B; Sung JJ; Yu J
    Oncotarget; 2014 Sep; 5(17):7663-76. PubMed ID: 25277196
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Caudatin inhibits carcinomic human alveolar basal epithelial cell growth and angiogenesis through modulating GSK3β/β-catenin pathway.
    Fei HR; Cui LY; Zhang ZR; Zhao Y; Wang FZ
    J Cell Biochem; 2012 Nov; 113(11):3403-10. PubMed ID: 22678744
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Caudatin induces cell apoptosis in gastric cancer cells through modulation of Wnt/β-catenin signaling.
    Li X; Zhang X; Liu X; Tan Z; Yang C; Ding X; Hu X; Zhou J; Xiang S; Zhou C; Zhang J
    Oncol Rep; 2013 Aug; 30(2):677-84. PubMed ID: 23708208
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Caudatin-2,6-dideoxy-3-O-methy-β-D-cymaropyranoside 1 induced apoptosis through caspase 3-dependent pathway in human hepatoma cell line SMMC7721.
    Peng YR; Ding YF; Wei YJ; Shu B; Li YB; Liu XD
    Phytother Res; 2011 May; 25(5):631-7. PubMed ID: 20981869
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Gai JQ; Sheng X; Qin JM; Sun K; Zhao W; Ni L
    Int J Oncol; 2016 Jan; 48(1):338-48. PubMed ID: 26648168
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Caudatin inhibits human hepatoma cell growth and metastasis through modulation of the Wnt/β-catenin pathway.
    Luo Y; Sun Z; Li Y; Liu L; Cai X; Li Z
    Oncol Rep; 2013 Dec; 30(6):2923-8. PubMed ID: 24064800
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
    Dahmani R; Just PA; Perret C
    Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132
    [TBL] [Abstract][Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.